Regeneron says its COVID-19 antibody therapy showed promise in hospitalized patients ...Middle East

Devdiscourse - Opinion
Regeneron says its COVID-19 antibody therapy showed promise in hospitalized patients
Regeneron Pharmaceuticals Inc said on Tuesday initial data from an ongoing study of its experimental antibody cocktail for use in some hospitalized COVID-19 patients show the therapy was sufficiently effective to warrant continuing the trial. The company is testing the therapy, a combination of two antibodies casirivimab and imdevimab, in hospitalized patients requiring low-flow oxygen.

Hence then, the article about regeneron says its covid 19 antibody therapy showed promise in hospitalized patients was published today ( ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Regeneron says its COVID-19 antibody therapy showed promise in hospitalized patients )

Apple Storegoogle play

Last updated :

Also on site :